Supplemental Methods

Materials
Poly(lactic acid-co-glycolic acid)-poly(ethylene glycol) (36,000 Da-3000 Da, LA/GA =1/1, Cat. No. AK29) was purchased from PolySciTech, Inc. (West Lafayette, IN, USA).
Dulbecco's phosphate buffer saline (DPBS) was purchased from Gibco by Life Technologies (Carlsbad, CA, USA). All other chemicals were purchased from Fisher Scientific or Sigma-Aldrich and used without further purification.
Preparation of CPPs.
CPPs were prepared as previously described. 17, 19, 21 Briefly, CP was oxidized to the precursor Pt(IV) complex, Pt(NH3)2(Cl)2(OH)2, using a tenfold excess of hydrogen peroxide in water and then collected via crystallization. The Pt(NH3)2(Cl)2(OH)2 complex was then acetylated with a range of lipid anhydrides. Butyric, octanoic, and decanoic anhydrides produced octahedral CPPs modified at the axial positions with fatty acid chains ranging from C4 (C4CP), C8 (C8CP), and C10 (C10CP), respectively.
Characterization of PLGA-PEG NPs.
NPs' size (nm) and surface charge (ζ-potential, mV) were characterized using a Zetasizer Nano Z dynamic light scattering detector (Malvern Instruments Ltd, Worcestershire, UK). Prior to the measurements, NPs were diluted to 1 mg/mL with PBS.
All reported values were based on the average of three separate measurements ( Fig. S2 ).
Transmission electron microscopy (TEM) images were recorded using a JEOL 100CX II TEM ( Fig. S3 ). Prior to TEM imaging, the concentrated NP samples were diluted by mixing with deionized water and negatively stained with 2% uranyl acetate on a 400-mesh carbon filmed copper grid. Excess NP dispersion was removed from the grid by dabbing with filter paper.
HPLC determination of drug concentration
NPs (10 μL) were mixed with acetonitrile (50 µL) and left overnight at 5 o C to destroy the NP structure. Drug amounts were measured using a Shimadzu SPD-M20A high-performance liquid chromatography (HPLC) instrument equipped with a diode array detector and a reverse-phase GP-C18 column (Sepax Technology Inc., Newark, DE, USA) ( Fig. 1, Fig. S2 ). Drugs were eluted using a binary solvent system (A:B, A-H2O, B-CH3CN, flow rate-0.25 mL/min) that linearly increased from 0% to 100% B over 20 min (0-20 min), held at 100% B for an additional 5 min (20-25 min), and then reduced to 50% B for the final 5 min (25-30 min). Eluents were monitored at 230 nm for DTX and 245 nm for CPPs. Retention times were as follows: DTX-11.6 min, C4CP-5.9 min, C8CP-12.9 min, and C10CP-15.9 min. Drug concentrations were determined using area under the curve integration in conjunction with DTX and CPP standard curves. 
